Edoxaban versus warfarin in patients with atrial fibrillation in relation to the risk of stroke: A secondary analysis of the ENGAGE AF-TIMI 48 study-Reference-Cited by-同舟云学术

Edoxaban versus warfarin in patients with atrial fibrillation in relation to the risk of stroke: A secondary analysis of the ENGAGE AF-TIMI 48 study

Published:2021-05 Issue: Volume:235 Page:132-139
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

de Groot Joris R.,Ruff Christian T.,Murphy Sabina A.,Hamershock Rose A.,Vehmeijer Jim T.,Oude Ophuis Anton J.M.,Grip Laura,Lanz Hans,Mercuri Michele F.,Antman Elliott M.,Giugliano Robert P.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference15 articles.

1. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials;Ruff;Lancet (London, England),2014

2. Higher incidence of ischemic stroke in patients taking novel oral anticoagulants;Shpak;Stroke,2018

3. Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial;Lopes;Lancet (London, England),2012

4. The CHA(2)DS(2)-VASc score predicts major bleeding in non-valvular atrial fibrillation patients who take oral anticoagulants;Lee;J Clin Med,2018

5. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation;January;Circulation,2019

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Residual Stroke Risk Among Patients With Atrial Fibrillation Prescribed Oral Anticoagulants: A Patient‐Level Meta‐Analysis From COMBINE AF;Journal of the American Heart Association;2024-09-03

2. Apixaban, edoxaban and rivaroxaban but not dabigatran are associated with higher mortality compared to vitamin‐K antagonists: A retrospective German claims data analysis;Journal of Internal Medicine;2024-09-02

3. Dose Reduction of Edoxaban in Patients 80 Years and Older With Atrial Fibrillation;JAMA Cardiology;2024-09-01

4. Very Elderly Patients With Atrial Fibrillation Treated With Edoxaban;JACC: Advances;2023-09

5. Bioequivalence and Pharmacokinetic Study of 2 Edoxaban Tablets in Healthy Chinese Subjects;Clinical Pharmacology in Drug Development;2022-08-11